Strides Pharma Science Limited announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced total revenue was INR 7,953.300 million compared to INR 7,644.500 million a year ago. Net income was INR 2,934.200 million compared to INR 854.800 million a year ago. Basic earnings per share from continuing operations was INR 2.41 compared to INR 5 a year ago. Diluted earnings per share from continuing operations was INR 2.41 compared to INR 4.99 a year ago. Basic earnings per share was INR 32.77 compared to INR 9.55 a year ago. Diluted earnings per share was INR 32.76 compared to INR 9.54 a year ago. For the nine months, total revenue was INR 22,097.900 million compared to INR 22,474.900 million a year ago. Net income was INR 2,771.000 million compared to INR 956.800 million a year ago. Basic earnings per share from continuing operations was INR 0.79 compared to INR 7.45 a year ago. Diluted earnings per share from continuing operations was INR 0.79 compared to INR 7.44 a year ago. Basic earnings per share was INR 30.94 compared to INR 10.69 a year ago. Diluted earnings per share was INR 30.94 compared to INR 10.68 a year ago.